18F-FLUC PET/MR in Patients With Brain Mets

The goal of this clinical trial is to use new imaging methods to help in finding out whether the imaging shows that there is a tumor in people with a brain metastasis. The main question it aims to answer is whether positron emission tomography (PET) and magnetic resonance imaging (MRI) find cancerous tissue better than other types of imagining. Participants will undergo a single PET/MRI scan, followed by a separate MRI scan with a tracer. Study participation will last about 3 hours.

NCT Number	NCT06159335
Lead Sponsor	University of Wisconsin, Madison Collaborators: Blue Earth Diagnostics
Conditions	Brain Metastasis, Radiation Therapy, Immunotherapy, Active
Enrollment	30 participants
Start Date	2024-01-10
Primary Completion	2027-06 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2026-06-22